John Simard - 23 Sep 2021 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Queena Han under Power of Attorney for John Simard
Issuer symbol
XBIT
Transactions as of
23 Sep 2021
Net transactions value
-$753,419
Form type
4
Filing time
28 Sep 2021, 10:59:07 UTC
Previous filing
22 Sep 2021
Next filing
01 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XBIT Common Stock Sale $145,220 -9,892 -0.24% $14.68 4,113,274 23 Sep 2021 Direct F1
transaction XBIT Common Stock Sale $165,409 -11,418 -0.28% $14.49 4,101,856 24 Sep 2021 Direct F1
transaction XBIT Common Stock Sale $442,790 -29,890 -0.73% $14.81 4,071,966 27 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

John Simard, CEO Chairman of XBiotech, Inc., adopted a stock trading plan. He sold total of 512,000 common stock on the open market as part of this 10B5-1 trading plan.